SOPHiA GENETICS SA Ordinary Shares (SOPH)
Summary
SOPH Chart
People also search for
SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last?
SOPHiA GENETICS (SOPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SOPHiA GENETICS SA (SOPH) Q2 2026 Earnings Call Transcript
SOPHiA GENETICS SA (SOPH) Q2 2026 Earnings Call Transcript
SOPHiA GENETICS Q2 Earnings Call Highlights
SOPHiA GENETICS NASDAQ: SOPH reported second-quarter revenue growth of 27% and raised its full-year revenue outlook, as the precision medicine software company cited accelerating U.S. adoption, liquid biopsy momentum and new biopharma agreements.
SOPHiA GENETICS SA Ordinary Shares Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 56 | $277.2 | $390.6 | $113.4 | 40.91% |
 Akre Capital Management Akre Capital Management LLC | 3.72M | $14.55M | $27.41M | $12.86M | 88.44% |
| PF Phillip Fitzsimmons Hennion & Walsh Asset Management Inc. | 118,262 | $755,002.76 | $826,060.07 | $71,057.31 | 9.41% |
 Taro Kuriyama Axq Capita LLP | 20,592 | $118,816 | $152,483.76 | $33,667.76 | 28.34% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 47 | $270.23 | $344.02 | $73.79 | 27.31% |
SOPHiA GENETICS SA Ordinary Shares (SOPH) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has SOPHiA GENETICS SA Ordinary Shares ever had a stock split?
SOPHiA GENETICS SA Ordinary Shares Profile
| Health Care Technology Industry | Healthcare Sector | Ross Muken CEO | NASDAQ (NGS) Exchange | H82027105 CUSIP |
| CH Country | 415 Employees | - Last Dividend | - Last Split | 23 Jul 2021 IPO Date |
Overview
SOPHiA GENETICS SA stands out as a pioneering cloud-native software technology company within the healthcare sector, specializing in the complex analysis of data to derive meaningful insights. Founded in 2011 with its headquarters in Rolle, Switzerland, SOPHiA GENETICS has quickly become a notable entity for leveraging cloud technology to facilitate advancements in healthcare analytics. The company's reach spans a global network, providing services through its direct sales force, distributors, and industry collaborators across various regions including Switzerland, France, Italy, the rest of Europe, North America (with a specific focus on the United States), Latin America, and the Asia-Pacific region. By marrying innovative technology with comprehensive data analysis, SOPHiA GENETICS is redefining the approach to healthcare diagnostics and research, making significant strides toward the future of personalized medicine and enhanced patient care.
Products and Services
- SOPHiA DDM Platform
- Related Solutions, Applications, Products, and Services
A sophisticated cloud-native software platform designed by SOPHiA GENETICS to offer unparalleled analysis of multimodal data sets and diagnostic modalities. This platform serves as the foundation for generating actionable insights, propelling the use of data-driven decision-making in healthcare. Aimed at transforming raw data into meaningful information, the SOPHiA DDM Platform is crucial for hospitals, laboratories, and biopharmaceutical companies striving toward the advancement of personalized medicine and better health outcomes.
In addition to the SOPHiA DDM platform, SOPHiA GENETICS offers a comprehensive range of related solutions, applications, products, and services tailored to meet the diverse needs of the healthcare industry. These offerings are designed to enhance the capabilities of the SOPHiA DDM platform, ensuring that clients have access to a full suite of tools for diagnostics, research, and development. The expansive availability of these sophisticated solutions demonstrates SOPHiA GENETICS's commitment to supporting healthcare professionals and researchers in their quests to uncover groundbreaking findings and improve patient care across the globe.
Contact Information
